1Kepes JJ, Louis DN, Gianini C, et al. Pleomorphic xanthoa- strocytoma [M]. In: Louis DN, Ohgaki H, Wieatler OD, et al. WHO Classification of the Cerntral Nervous System. 4th ed. Lyon: IARC Press, 2007.22.
3Reifenberher G, Kaulich K, Wiester OD, et al. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas [J]. Acta Neuropathol, 2003, 105: 358-364.
4Kumar R, Singh V. Subependymal giant cell astreytoma: a report of five cases [J]. Neurosurg Rev, 2004, 27(4): 274- 280.
5Sharma MC, Ralte AM, Gaekwad S, et al. Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis [J]. Pathol Oncol Res, 2004, 10: 219-224.
6Mathias P, Alexander H, Klaus N, et al. Angioeentric glioma, report of clinieopathologic and genetic findings in 8 cases [J}. Am J Surg Pathol, 2007, 3(11): 1709-1718.
8Ganesan K, Desai S, Udwedia-Hegde A. Non-in-fantile va- riant of desmoplastic ganglioglioma: a report of 2 cases [J]. Pediatr Radiol, 2006, 36: 541-545.
9Trehan G, Bruge H, Vinchon M, et al. MR imaging in the diagnosis of desmopective study of six cases [J]. Am J Neu- roracdiol, 2004, 25: 1028-1033.
10Kleihues P, Cavenee WK. Pathology and genetics: tumors of nervous system [M]. In: World health organisstion classifi- cation of tumours. 3th ed. Lyon: IARC Press, 2000, 95-112.
3Riva M. Brain tumoral epilepsy: a review [J]. Neurol Sci, 2005, 26(Suppl 1): S40-50.
4Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resectionin 332 patients with low- grade gliomas [J]. J Neurosurg, 2012, 108: 227-235.
5Chaichana KL, Parker SL, Olivi A, et al. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas [J]. J Neurosurg, 2009, 111: 282-292.
6Yang Y, Wang X, Liu YH, et al. Ki-67 overexpression in WHO grade Ⅱ gliomas is associated with poor postopera- tive seizure control [J]. Seizure, 2013, 22(10): 877-881.
7You G, Sha ZY, Yan W, et al. Seizure characteristics and outcomes in 508 Chinese adult patients undergoing prima- ryresection of low-grade gliomas: a clinicopathological study [J]. Neuro Oncol, 2012, 14(2): 230-241.
8Liubinas SV, D'Abaco GM, Moffat BM, et al. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas [J]. Epilepsia, 2014, 55(9): 1438-1443.
9Stockhammer F, Misch M, Helms HJ, et al. IDH1/2 muta- tions in WHO gradeⅡastrocytomas associated with locali- zation and seizure as the initial symptom [J]. Seizure, 2012, 21: 194-197.
10Zhong Z, Wang Z, Wang Y, et al. IDH1/2 mutation is asso- ciated with seizure as an initial symptom in low-grade gli- oma: a report of 311 Chinese adult glioma patients [J]. Epi- lepsy Res, 2015, 109: 100-105.
